SCD and Alzheimer disease: In this review we describe how its ability to inhibit stearoyl-CoA desaturase (SCD) directly, can be of interest as a coadjuvant for the treatment for various diseases, such as, nonalcoholic steatohepatitis, Alzheimer’s disease, cancer, and retinal disorders.